يعرض 1 - 10 نتائج من 120 نتيجة بحث عن '"Sydes, M R"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://orca.cardiff.ac.uk/id/eprint/163154/1/13063_2023_Article_7656.pdfTest; Mitchell, E. J., Appelbe, D., Bravery, A., Culliford, L., Evans, H., Farrin, A. J., Gillies, K., Hood, K. https://orca.cardiff.ac.uk/view/cardiffauthors/A075757S.htmlTest orcid:0000-0002-5268-8631 orcid:0000-0002-5268-8631, Love, S. B., Sydes, M. R., Williamson, P. R. and Wakefield, N. 2023. e-Consent in UK academic-led clinical trials: current practice, challenges and the need for more evidence. Trials 24 , 657. 10.1186/s13063-023-07656-8 https://doi.org/10.1186/s13063-023-07656-8Test file https://orca.cardiff.ac.uk/id/eprint/163154/1/13063_2023_Article_7656.pdfTest

  2. 2
    دورية أكاديمية

    المساهمون: Gillessen S., Bossi A., Davis I.D., de Bono J., Fizazi K., James N.D., Mottet N., Shore N., Small E., Smith M., Sweeney C.J., Tombal B., Antonarakis E.S., Aparicio A.M., Armstrong A.J., Attard G., Beer T.M., Beltran H., Bjartell A., Blanchard P., Briganti A., Bristow R.G., Bulbul M., Caffo O., Castellano D., Castro E., Cheng H.H., Chi K.N., Chowdhury S., Clarke C.S., Clarke N., Daugaard G., De Santis M., Duran I., Eeles R., Efstathiou E., Efstathiou J., Ekeke O.N., Evans C.P., Fanti S., Feng F.Y., Fonteyne V., Fossati N., Frydenberg M., George D., Gleave M., Gravis G., Halabi S., Heinrich D., Herrmann K., Higano C., Hofman M.S., Horvath L.G., Hussain M., Jereczek-Fossa B.A., Jones R., Kanesvaran R., Kellokumpu-Lehtinen P.-L., Khauli R.B., Klotz L., Kramer G., Leibowitz R., Logothetis C., Mahal B., Maluf F., Mateo J., Matheson D., Mehra N., Merseburger A., Morgans A.K., Morris M.J., Mrabti H., Mukherji D., Murphy D.G., Murthy V., Nguyen P.L., Oh W.K., Ost P., O'Sullivan J.M., Padhani A.R., Pezaro C.J., Poon D.M.C., Pritchard C.C., Rabah D.M., Rathkopf D., Reiter R.E., Rubin M.A., Ryan C.J., Saad F., Sade J.P., Sartor O., Scher H.I., Sharifi N., Skoneczna I., Soule H., Spratt D.E., Srinivas S., Sternberg C.N., Steuber T., Suzuki H.

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37003085; info:eu-repo/semantics/altIdentifier/wos/WOS:000992006000001; volume:185; firstpage:178; lastpage:215; numberofpages:38; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11585/957722Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85151286476; https://www.sciencedirect.com/science/article/pii/S0959804923001107Test

  3. 3
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.soton.ac.uk/453410/1/1_s2.0_S1551714421002214_main.pdfTest; Bass, E J, Klimowska-Nassar, N, Sasikaran, T, Day, E, Fiorentino, F, Sydes, M R, Winkler, M, Arumainayagam, N, Khoubehi, B, Pope, A, Sokhi, H, Dudderidge, T and Ahmed, H U (2021) PROState pathway embedded comparative trial: the IP3-PROSPECT study. Contemporary Clinical Trials, 107, [106485]. (doi:10.1016/j.cct.2021.106485 ).

  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المساهمون: MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK

    العلاقة: https://dx.doi.org/10.1016/s1470-2045Test(23)00230-9; Vale CL, Fisher DJ, Godolphin PJ, Rydzewska LH, Boher JM, Burdett S, et al. Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials. The Lancet Oncology. 2023 Jul;24(7):783-97. PubMed PMID: 37414011. Epub 2023/07/07. eng.; http://hdl.handle.net/10541/626442Test; Lancet Oncology

  6. 6
    دورية أكاديمية

    المساهمون: Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    العلاقة: https://dx.doi.org/10.1016/j.ijrobp.2023.04.032Test; Petersen PM, Cook AD, Sydes MR, Clarke N, Cross W, Kynaston H, et al. Salvage radiotherapy after radical prostatectomy: analysis of toxicity by dose-fractionation in the RADICALS-RT trial. International journal of radiation oncology, biology, physics. 2023 May 5. PubMed PMID: 37150260. Epub 2023/05/08. eng.; http://hdl.handle.net/10541/626296Test; International Journal of Radiation Oncology Biology Physics

  7. 7
    دورية أكاديمية

    المساهمون: Cancer Institute, University College London, London, UK, University College London Hospitals, London, UK

    العلاقة: https://dx.doi.org/10.1016/s1470-2045Test(23)00148-1; Attard G, Murphy L, Clarke NW, Sachdeva A, Jones C, Hoyle A, et al. Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol. The Lancet Oncology. 2023 May;24(5):443-56. PubMed PMID: 37142371. Epub 2023/05/05. eng.; http://hdl.handle.net/10541/626288Test; Lancet Oncology

  8. 8
    دورية أكاديمية

    المساهمون: MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, 90 High Holborn, London WC1V 6LJ, UK

    العلاقة: https://dx.doi.org/10.1016/j.cct.2023.107162Test; Macnair A, Nankivell M, Murray ML, Rosen SD, Appleyard S, Sydes MR, et al. Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected data. Contemporary clinical trials. 2023 Mar 16;128:107162. PubMed PMID: 36933612. Epub 2023/03/19. eng.; http://hdl.handle.net/10541/626168Test; Contemporary Clinical Trials

  9. 9
    دورية أكاديمية
  10. 10
    مؤتمر

    المساهمون: Genito-Urinary Cancer Research Group, The University of Manchester, Manchester,UK

    العلاقة: https://dx.doi.org/10.1016/j.annonc.2022.07.1946Test; Haran AM, Jain Y, Hambrock T, Murphy LR, Cook A, Brown LC, et al. Differential treatment response with nodal metastases in metastatic hormone-sensitive prostate cancer (mHSPC) and evaluation of nodal (N) burden as a prognostic biomarker: Ancillary studies of the docetaxel and abiraterone acetate and prednisolone (AAP) phase III trials from STAMPEDE. Annals of Oncology. 2022 Sep;33(7):S1161-S2. PubMed PMID: WOS:000866211601616.; http://hdl.handle.net/10541/625974Test; Annals of Oncology